title: First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer.
authors.affiliation: 1] INSERM U965, Hôpital Lariboisière, Paris, France [2] Université Paris Diderot-Paris 7, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Besbes
authors.affiliation: 1] INSERM U965, Hôpital Lariboisière, Paris, France [2] Université Paris Diderot-Paris 7, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Billard
mesh_terms: D000814:Aniline Compounds / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D006801:Humans; D064549:Myeloid Cell Leukemia Sequence 1 Protein / Q000037:antagonists & inhibitors*; D009369:Neoplasms / Q000473:pathology*; D054852:Small Molecule Libraries / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D000814:Aniline Compounds; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D054852:Small Molecule Libraries; D013449:Sulfonamides